NASDAQ: KPRX
Kiora Pharmaceuticals Inc Stock Ownership - Who owns Kiora Pharmaceuticals?

Insider buying vs selling

Have Kiora Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric Joseph DanielsChief Development Officer2026-04-01929$1.95
$1.81kSell
Brian M. StremPresident and CEO2026-04-011,906$1.95
$3.72kSell
Melissa ToscaCFO2026-04-01929$1.95
$1.81kSell
Eric Joseph DanielsChief Development Officer2026-03-03238$2.02
$480.76Sell
Brian M. StremPresident and CEO2026-03-03238$2.02
$480.76Sell

1 of 1

KPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KPRX insiders and whales buy or sell their stock.

KPRX Shareholders

What type of owners hold Kiora Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC168.73%7,478,202$18.02MInsider
Innoven Partenaires Sa Ipsa32.95%1,460,479$3.52MInsider
Ventech Capital II32.31%1,431,814$3.45MInsider
Private Equity Natixis15.21%674,205$1.62MInsider
Barbara Wirostko10.47%463,808$1.12MInsider
Michael Garanzini4.43%196,250$472.96kInsider
Adar1 Capital Management LLC3.79%167,941$404.74kInstitution
Stonepine Capital Management LLC2.96%131,144$316.06kInstitution
Drw Securities LLC2.49%110,282$265.78kInstitution
Nantahala Capital Management LLC2.40%106,156$255.84kInstitution

1 of 3

KPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KPRX5.46%94.54%Net SellingNet Selling
HOTH6.07%49.70%Net Selling
KAPA4.00%35.51%
APRE2.77%97.23%Net Buying
IMNN4.60%95.40%Net Buying

Kiora Pharmaceuticals Stock Ownership FAQ

Who owns Kiora Pharmaceuticals?

Kiora Pharmaceuticals (NASDAQ: KPRX) is owned by 15.95% institutional shareholders, 276.39% Kiora Pharmaceuticals insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Kiora Pharmaceuticals shareholder, owning 7.48M shares representing 168.73% of the company. Armistice Capital LLC's Kiora Pharmaceuticals shares are currently valued at $18.25M.

If you're new to stock investing, here's how to buy Kiora Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.